These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9610106)

  • 21. Low selection of preneoplastic hepatocytes after treatment with the 2-acetylaminofluorene diet-partial hepatectomy regimen in the liver of hepatocarcinogenesis-resistant DRH strain rats.
    Imai K; Yamamoto M; Tanaka H; Hashimoto N; Miyakoshi M; Honmou S; Yoshie M; Tamakawa S; Yaginuma Y; Kasai S; Ogawa K
    Oncol Rep; 2007 Jan; 17(1):55-60. PubMed ID: 17143478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of autophagy promotes the growth of early preneoplastic rat liver nodules.
    Kowalik MA; Perra A; Ledda-Columbano GM; Ippolito G; Piacentini M; Columbano A; Falasca L
    Oncotarget; 2016 Feb; 7(5):5788-99. PubMed ID: 26735341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The significance of selected biochemical markers in the characterization of putative initiated cell populations in rodent liver.
    Pitot HC; Glauert HP; Hanigan M
    Cancer Lett; 1985 Oct; 29(1):1-14. PubMed ID: 2866027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Molecular and metabolic changes in human clear cell liver foci].
    Ribback S; Calvisi DF; Cigliano A; Rausch J; Heidecke CD; Birth M; Dombrowski F
    Pathologe; 2015 Nov; 36 Suppl 2():210-5. PubMed ID: 26483250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduction of glutathione S-transferase P-form mRNA expression in remodeling nodules in rat liver revealed by in situ hybridization.
    Imai T; Masui T; Ichinose M; Nakanishi H; Yanai T; Masegi T; Muramatsu M; Tatematsu M
    Carcinogenesis; 1997 Mar; 18(3):545-51. PubMed ID: 9067555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apolipoprotein A-IV mRNA overexpression in early preneoplastic hepatic foci induced by low-number pancreatic islet transplants in streptozotocin-diabetic rats.
    Evert M; Schneider-Stock R; Dombrowski F
    Pathol Res Pract; 2003; 199(6):373-9. PubMed ID: 12924437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multistage hepatocarcinogenesis in the rat: insights into risk estimation.
    Dragan YP; Pitot HC
    Prog Clin Biol Res; 1992; 374():261-79. PubMed ID: 1620707
    [No Abstract]   [Full Text] [Related]  

  • 28. Expression of transforming growth factor (TGF)-beta1 and TGF-beta type II receptor in preneoplastic lesions during chemical hepatocarcinogenesis of rats.
    Park DY; Hwang SY; Suh KS
    Toxicol Pathol; 2001; 29(5):541-9. PubMed ID: 11695571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biological markers characterizing the development of preneoplastic and neoplastic lesions in rodent liver.
    Beer DG; Pitot HC
    Arch Toxicol Suppl; 1987; 10():68-80. PubMed ID: 2883960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Compensatory apoptosis in preneoplastic liver of a transgenic mouse model for viral hepatocarcinogenesis.
    Koike K; Moriya K; Yotsuyanagi H; Shintani Y; Fujie H; Tsutsumi T; Kimura S
    Cancer Lett; 1998 Dec; 134(2):181-6. PubMed ID: 10025879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative analysis of multiple phenotype enzyme-altered foci in rat hepatocarcinogenesis experiments: the multipath/multistage model.
    Sherman CD; Portier CJ
    Carcinogenesis; 1995 Oct; 16(10):2499-506. PubMed ID: 7586158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neoplastic progression in experimental hepatocarcinogenesis.
    Scherer E
    Biochim Biophys Acta; 1984; 738(4):219-36. PubMed ID: 6394049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular pathology of early stage chemically induced hepatocarcinogenesis.
    Ogawa K
    Pathol Int; 2009 Sep; 59(9):605-22. PubMed ID: 19712128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stochastic analysis of intermediate lesions in carcinogenesis experiments.
    Luebeck EG; Moolgavkar SH
    Risk Anal; 1991 Mar; 11(1):149-57. PubMed ID: 1828119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of multiple cell cycle aberrations in early preneoplastic liver cell lesions by tumor promotion with thioacetamide in a two-stage rat hepatocarcinogenesis model.
    Kimura M; Fujii Y; Yamamoto R; Yafune A; Hayashi SM; Suzuki K; Shibutani M
    Exp Toxicol Pathol; 2013 Nov; 65(7-8):979-88. PubMed ID: 23474136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A method for parametric estimation of the number and size distribution of cell clusters from observations in a section plane.
    de Gunst MC; Luebeck EG
    Biometrics; 1998 Mar; 54(1):100-12. PubMed ID: 9544509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic resistance to chemical carcinogen-induced preneoplastic hepatic lesions in DRH strain rats.
    Zeng ZZ; Higashi S; Kitayama W; Denda A; Yan Y; Matsuo K; Konishi Y; Hiai H; Higashi K
    Cancer Res; 2000 Jun; 60(11):2876-81. PubMed ID: 10850431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA oxidative damage of neoplastic rat liver lesions.
    Marengo B; De Ciusis C; Ricciarelli R; Romano P; Passalacqua M; Marinari UM; Pronzato MA; Domenicotti C
    Oncol Rep; 2010 May; 23(5):1241-6. PubMed ID: 20372836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative aspects of chemical carcinogenesis and tumor promotion in liver.
    Kunz HW; Tennekes HA; Port RE; Schwartz M; Lorke D; Schaude G
    Environ Health Perspect; 1983 Apr; 50():113-22. PubMed ID: 6223810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of phenobarbital-mediated promotion of hepatocarcinogenesis in connexin32-null mice.
    Moennikes O; Buchmann A; Romualdi A; Ott T; Werringloer J; Willecke K; Schwarz M
    Cancer Res; 2000 Sep; 60(18):5087-91. PubMed ID: 11016633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.